VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

VJVirtual | Chromothripsis and chromoplexy in myeloma

Gareth Morgan • 10 Apr 2020
Multiple Myeloma

Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Medical Center, New York, NY, discusses chromothripsis and chromoplexy, and how these may help in the clinical management of patients with myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Gareth Morgan

1:19
MRD testing should be more widely available
Gareth Morgan • 15 Jun 2018
4:29
Smoldering myeloma: monitoring patients and deciding when to treat
Gareth Morgan • 8 Apr 2020
5:35
Contemporary designs for multiple myeloma treatment
Gareth Morgan • 14 Jun 2018
1:43
Novel anti-BCMA immunotherapies have unprecedented responses
Gareth Morgan • 14 Jun 2018

Related Videos

2:55
Bispecific antibodies for myeloma: highlights from ASH 2020
Saad Usmani • 17 Dec 2020
1:33
Ide-cel CAR T-cell therapy in newly diagnosed high-risk myeloma
Saad Usmani • 17 Dec 2020
3:22
Anti-BCMA CAR T-cell therapy in myeloma: updates from ASH 2020
Saad Usmani • 17 Dec 2020
2:31
Cilta-cel achieves deep and durable responses for R/R multiple myeloma
Thomas Martin • 17 Dec 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals